Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?
Andrew GengosSee Below2023-06-07422$3.36
Andrew GengosSee Below2023-06-0711,719$3.44
Andrew GengosSee Below2023-06-072,859$3.40
Andrew GengosSee Below2023-06-0515,000$3.00
Andrew GengosSee Below2023-06-0510,000$3.02
Andrew GengosSee Below2023-06-0510,000$3.00
Andrew GengosSee Below2023-06-0510,000$3.00
Hans MoebiusChief Medical Officer2023-06-027,882$1.35
Andrew GengosSee Below2023-06-023,418$2.95
Andrew GengosSee Below2023-06-026,582$2.86

1 of 2

ATHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?
Perceptive Advisors LLC12.61%4,797,278$6.91MInsider
Perceptive Advisors LLC12.61%4,797,278$6.91MInstitution
Baker Bros Advisors LP8.29%3,153,807$4.54MInstitution
Joseph Edelman8.19%3,114,805$4.49MInsider
Rtw Investments LP7.01%2,668,913$3.84MInsider
Bml Capital Management LLC4.48%1,704,362$2.45MInstitution
Vanguard Group Inc4.46%1,698,453$2.45MInstitution
Simplify Asset Management Inc3.92%1,492,792$2.15MInstitution
Point72 Asset Management LP2.38%907,558$1.31MInstitution
Millennium Management LLC1.95%742,343$1.07MInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA56.32%29.88%Net Buying
COYA14.12%19.38%Net Buying
SYRS37.02%62.98%Net SellingNet Selling
AVRO49.06%50.94%Net Buying

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 56.32% institutional shareholders, 29.88% Athira Pharma insiders, and 13.80% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 4.80M shares representing 12.61% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $6.91M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.